Výsledky vyhledávání - "A. V. Alesenko"

Studies of the Efficacy of Cereton in Mild Cognitive Impairment of the Amnestic Type Based on Testing Lipid Markers

Autor: Selezneva Nd, Gavrilova Si, Ya. B. Fedorova, E. V. Ponomareva, U A Gutner, A. V. Alesenko, I. V. Kolykhalov, M. A. Shupik, A. O. Lebedeva

Publikováno v: Neuroscience and Behavioral Physiology. 49:147-152

Objectives. To determine the efficacy and safety of treatment with Cereton (alfoscerate) in patients with mild cognitive impairment syndrome (MCI) and its effects during and after treatment on phosphatidyl-choline, sphingomyelin, and ceramide (a sphi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ca2067db822dea68724120b877a4accd
https://doi.org/10.1007/s11055-018-0708-z

Zobrazit plný text záznamu

[Development of early diagnosis of Parkinson's disease based on the search for biomarkers such as premotor symptoms and changes in blood]

Autor: Michael V. Ugrumov, Gusev Ei, M. A. Shupik, S A Sokolov, U A Gutner, D. A. Katunin, A. V. Alesenko, Malykhina Ea, Olga A. Maloshitskaya, V. G. Kucheryanu, M. R. Nodel, A. L. Kalinkin, N V Titova, V. E. Blokhin, M. Yu. Martinov, E A Katunina, E. N. Pavlova

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 120(12)

To determine changes in the chemical composition of blood plasma in subjects at risk of Parkinson's disease (PD) at the prodromal stage compared with age control.Subjects at risk were selected for the presence of characteristic premotor symptoms, inc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14442ada431563ba02e041eeaf6c2548
https://pubmed.ncbi.nlm.nih.gov/33459535

Zobrazit plný text záznamu

Development of early diagnosis of Parkinson’s disease and comprehensive economic analysis of the effect of its implementation

Autor: A V Alesenko, T. S. Pronina, S A Vartanov, Gusev Ei, A. L. Kalinkin, M Yu Martynov, I A Denisova, S A Sokolov, T V Chubarova, M. R. Nodel, V. G. Kucheryanu, Victor Polterovich, V. E. Blokhin, M. A. Shupik, M V Shakleina, E A Katunina, M. V. Ugryumov, E. N. Pavlova

Publikováno v: Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 121:9

The paper summarizes the literature and author's data on the development of early (preclinical) diagnosis of Parkinson's disease (PD). Implementation of this diagnosis will promote the use of preventive therapy and change investments in diagnosis and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7d88643cb46ec64017ce0cf1b80159d
https://doi.org/10.17116/jnevro20211210119

Zobrazit plný text záznamu

[Detection of effective treatment of amnestic mild cognitive impairement with cereton by testing of lipids markers]

Autor: U A Gutner, Kolykhalov, Ya. B. Fedorova, M. A. Shupik, E. V. Ponomareva, A. V. Alesenko, A. O. Lebedeva, Selezneva Nd, Gavrilova Si

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 117(6)

Determination of effectivity and safety of Cereton (Choline alfoscerate, production by Sotex) 1200 mg/day in the treatment of cognitive functioning disorders in patients with amnestic mild cognitive impairment (aMCI) and determining its influence in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3aeba8f1bf2067658ca029617a0c159
https://pubmed.ncbi.nlm.nih.gov/28745666

Zobrazit plný text záznamu

[The potential role for sphingolipids in neuropathogenesis of Alzheimer's disease]

Autor: A V, Alesenko

Publikováno v: Biomeditsinskaia khimiia. 59(1)

The review discusses the functional role of sphingolipids in the pathogenesis of Alzheimer's disease. Certain evidence exist that the imbalance of sphingolipids such as sphingomyelin, ceramide, sphingosine, sphingosine-1-phosphate and galactosylceram

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::15990b122b694d45107aa1770efd85c1
https://pubmed.ncbi.nlm.nih.gov/23650721

Zobrazit plný text záznamu

[Features of memantine action profile in cholinergic deficit and intracerebral posttraumatic hematoma (hemorrhagic stroke) models in rats]

Autor: T L, Garibova, T A, Voronina, S A, Litvinova, A L, Kuznetsova, A E, Kul'chikov, A V, Alesenko

Publikováno v: Eksperimental'naia i klinicheskaia farmakologiia. 71(2)

Memantine, a low-affinity non-competitive antagonist of glutamatergic NMDA-subtype receptors, was used at a daily dose of 1 mg/kg over 10 days for the treatment of rats with cholinergic deficit induced by the chronic administration of scopolamine (1

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::08758d869bd6b5eed4ab67516b40dcb4
https://pubmed.ncbi.nlm.nih.gov/18488899

Zobrazit plný text záznamu

[Relationship of tumor necrosis factor alpha expression with activation of sphingomyelinase and lipid peroxidation after removal of cholestatic factor]

Autor: L B, Dudnik, A N, Tsiupko, M A, Shupik, G G, Akhaladze, E I, Gal'perin, L V, Platonova, E A, Pantaz, V V, Iasnetsov, L D, Smirnov, A V, Alesenko

Publikováno v: Izvestiia Akademii nauk. Seriia biologicheskaia. (1)

The goal of this work was to study the expression of tumor necrosis factor alpha (TNFalpha), sphingomyelin cycle activation, and lipid peroxidation (LPO) processes after the removal of a cholestatic factor in the liver subjected to different duration

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::51eb0c18056f79532410563682667041
https://pubmed.ncbi.nlm.nih.gov/17352195

Zobrazit plný text záznamu

[Changes in sphingomyelinase activity, tumor necrosis factor alpha level, and lipid peroxidation rate in the course of development of cholestatic liver injury]

Autor: L B, Dudnik, A N, Tsiupko, L N, Shingarova, M A, Shupik, G G, Akhaladze, E I, Gal'perin, L V, Platonova, N I, Shono, V V, Iasnetsov, A V, Alesenko

Publikováno v: Izvestiia Akademii nauk. Seriia biologicheskaia. (6)

Changes in sphingomyelinase activity, tumor necrosis factor alpha expression, and lipid peroxidation rate in the course of development of cholestatic liver injury have been studied. The same type phase shifts in the parameters analyzed were observed,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::c38bf41b10c1132319c664241ac086e9
https://pubmed.ncbi.nlm.nih.gov/16535974

Zobrazit plný text záznamu

[The influence of tumor necrosis factor alpha on the processes of sphingomyelin cycle and lipid peroxidation in brain]

Autor: U A, Gutner, L B, Dudnik, V G, Korobko, A V, Alesenko

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 105(4)

The influence of tumor necrosis factor alpha (TNF-alpha) on the processes of sphingomyelin cycle activation and intensity of peroxidation in animal brain in vivo has been studied. Alterations in activity of sphingomyelinase, a key sphingomyelin cycle

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::210f7d480e6c909c79f24ea8424ab0d5
https://pubmed.ncbi.nlm.nih.gov/15875943

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání